APA (7th ed.) Citation

M, D., B, B., J, N., A, B., D, M., H, N. B., . . . T, J. (2021). Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates. Transplantation direct, 7(5), e690. https://doi.org/10.1097/TXD.0000000000001139

Chicago Style (17th ed.) Citation

M, Daligault, et al. "Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates." Transplantation Direct 7, no. 5 (2021): e690. https://doi.org/10.1097/TXD.0000000000001139.

MLA (9th ed.) Citation

M, Daligault, et al. "Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates." Transplantation Direct, vol. 7, no. 5, 2021, p. e690, https://doi.org/10.1097/TXD.0000000000001139.